U.S. Healthcare Services Stock News

Joby Aviation (JOBY) is drawing fresh attention after flying its FAA conforming eVTOL aircraft, conducting high profile urban demonstration flights, and advancing within U.S. government pilot programs that support real world air taxi testing. See our latest analysis for Joby Aviation. Against this backdrop of FAA progress, urban test flights and high profile investors increasing exposure, Joby’s share price has been volatile, with a 30 day share price return of 10.18% but a year to date share...

DENTSPLY SIRONA (XRAY) stock has drawn attention after a period of weak share performance, with the price around $9.84 and total returns down over the past year and over the past 3 months. See our latest analysis for DENTSPLY SIRONA. The recent 1-day share price return of 1.03% sits against a 30-day share price return that is down 23.06% and a 1-year total shareholder return that is down 35.47%, suggesting momentum has been fading rather than building. If this kind of volatility has you...

Cirion Technologies launched a Network-as-a-Service platform using Ciena's optical technology for automated, real-time connectivity across Latin American data centers and AI environments. The platform offers on-demand, programmable optical links through a digital interface, aimed at enterprises that need flexible, high-capacity networking. This marks a commercial deployment of NYSE:CIEN solutions beyond traditional telecom operators, into a broader enterprise connectivity setting. For...

Wondering if IQVIA Holdings at around US$171.50 is offering value right now, or if you are paying up for growth expectations that may already be in the price. The stock is roughly flat over the past week, down around 3% over the past month and down 23.9% year to date, yet it is still up 24.9% over the past year. This can leave investors questioning whether the recent weakness signals changing risk sentiment or just normal volatility. Recent headlines have focused on IQVIA Holdings' role in...

Wondering whether Littelfuse at around US$441 per share still offers value or if the easy gains are behind it? This article walks through what the current price may say about expectations baked into the stock. The share price has been through a sharp pullback of about 8.3% over the past week, after a strong 11.8% move over the last month and sizeable returns of 68.1% year to date and 111.9% over the past year. Recent headlines around Littelfuse have focused on its positioning within the...

What triggered fresh interest in Nordic American Tankers? Recent analyst upgrades on Nordic American Tankers (NAT) followed sharply higher full year earnings estimates, while newly secured vessel contracts at premium day rates highlighted demand for its Suezmax crude fleet. See our latest analysis for Nordic American Tankers. At a share price of US$5.60, Nordic American Tankers has seen its 90 day share price return of 15.94% and year to date share price return of 66.17%. The 1 year total...

NIO (NYSE:NIO) continues to attract attention after recent share price swings, with the stock down 16.1% over the past month, up 13.4% over the past 3 months, and up 41.9% over the past year. See our latest analysis for NIO. Recent trading shows momentum has cooled, with the share price down 16.1% over the past month but still ahead over the past year, while the 1 year total shareholder return sits at 41.9% despite weaker multi year outcomes. If NIO has you watching the electric vehicle space...

In May 2026, ZoomInfo Technologies Inc. reported first-quarter revenue of US$310.2 million with higher net income year over year, expanded its revolving credit commitments to US$276.0 million, lowered its full-year 2026 revenue outlook, and subsequently became the subject of a shareholder investigation into its earlier upbeat guidance. This combination of softer forward guidance, increased legal scrutiny, and additional financing flexibility raises important questions about ZoomInfo’s growth...

Novo Nordisk (NYSE:NVO) has announced a new partnership with OpenAI to embed artificial intelligence across drug discovery, manufacturing, and supply chain operations. The collaboration aims to integrate AI tools into core workflows, with a focus on research productivity, production efficiency, and logistics planning. This move comes as Novo Nordisk responds to rising competitive pressure in its key therapeutic areas. Novo Nordisk, trading at $45.07, is taking a different kind of step by...

ZTO Express (Cayman) (NYSE:ZTO) has entered Q1 2026 on the back of a busy 2025, with Q4 revenue of C¥14.5b and basic EPS of C¥3.31 capping off a year in which trailing 12 month revenue reached C¥49.1b and EPS came in at C¥11.38. Over recent quarters the company has seen revenue move from C¥10.9b in Q1 2025 to C¥11.9b in Q3 and then C¥14.5b in Q4, while quarterly EPS tracked from C¥2.50 to C¥3.16 and then C¥3.31, setting up Q1 2026 against a backdrop of steady top line and earnings...

Investors may be wondering whether Black Stone Minerals, at around US$13.93, is offering good value right now or if most of the potential upside is already reflected in the price. The stock has returned 2.8% over the past week, 1.2% over the past month, 3.1% year to date and 12.9% over the last year. This naturally raises questions about how much risk and reward are currently embedded in the price. Recent coverage has focused on Black Stone Minerals as an income-oriented US energy stock and...

If you are wondering whether Alphabet stock still offers value after its strong run, or if most of the opportunity is already priced in, this article breaks down what the current share price might be indicating. Alphabet closed at US$388.91, with returns of 15.3% over the past month, 23.4% year to date, and 131.5% over the past year, although the stock has declined 3.4% in the last week. Recent news around Alphabet has focused on the company's role in artificial intelligence, cloud services,...

If you are wondering whether Tanger is still good value after a strong run, or if you might be arriving late to the story, this article focuses squarely on what the current price could imply. The stock closed at US$35.63, with returns of 0.6% over 7 days, a decline of 4.1% over 30 days, 7.6% year to date, 24.9% over 1 year and roughly a 2x gain over 3 years and 1.5x over 5 years. This naturally raises questions about what is already priced in. Recent headlines around Tanger have largely...

If you are wondering whether Omnicell's current share price still reflects good value or if most of the opportunity is already priced in, the starting point is understanding how its valuation stacks up across several methods. Over the past year, the stock is up 63.6%, with a 3.6% gain over the last week and 18.3% over the past month, even though the year to date return is slightly down at 0.9% and longer term 3 year and 5 year returns are lower at 38.8% and 67.7% respectively. These price...

Why Visteon Stock Is Back on Investors’ Radar Visteon (VC) has drawn fresh attention after a recent move in the share price, with the stock up 4.0% over the past day, 7.7% over the past month, and 16.3% in the past 3 months. See our latest analysis for Visteon. The latest move comes after a mixed few months, with a 16.3% 3 month share price return contributing to a 12.7% year to date gain. However, the 1 year total shareholder return of 31.4% contrasts with weaker 3 and 5 year total...

Apple (NasdaqGS:AAPL) introduced new Apple Intelligence powered accessibility features, including eye tracking control for wheelchairs and on device generated subtitles, across its device ecosystem. The company also announced a major hardware reorganization, with Johny Srouji overseeing the reshaped hardware structure to deepen AI integration in devices. Apple confirmed that John Ternus is set to become CEO in September, aligning leadership with its AI focused hardware roadmap. For Apple,...

Structure Therapeutics (GPCR) drew fresh attention after reporting first quarter results for the period ended March 31, 2026, with a net loss of US$75.97 million compared with US$46.83 million a year earlier. See our latest analysis for Structure Therapeutics. The first quarter update and wider clinical pipeline work have come against a backdrop of a share price that is down 23.5% over the past month and 45.9% year to date, while the 1 year total shareholder return of 52.7% and 3 year total...

Why Evergy’s latest earnings matter for shareholders Evergy (EVRG) released first quarter results for the period ended March 31, 2026, reporting sales of US$1,443.7 million and net income of US$151.5 million. Both figures are above the levels reported a year earlier. See our latest analysis for Evergy. The earnings update comes after a steady run in the stock, with a year-to-date share price return of 13.79% and a 1-year total shareholder return of 30.14%. This suggests momentum has been...

IDEAYA Biosciences (IDYA) is back in focus after reporting OptimUM-02 data showing longer median progression-free survival for its lead melanoma drug, darovasertib, and signaling plans for an NDA filing and broader pipeline expansion. See our latest analysis for IDEAYA Biosciences. IDEAYA's recent darovasertib update comes after a choppy few months, with the share price up 4.7% over the last day and 2.6% over the past week, but down around 12% year to date. The 1 year total shareholder return...

Powell Industries (POWL) is in focus after securing several large electric utility and data center contracts in the fiscal second quarter of 2026, which built a record order backlog and drew fresh earnings estimate revisions. See our latest analysis for Powell Industries. At a share price of $271.05, the stock has given investors a 12.17% 30 day share price return and a very large 1 year total shareholder return, suggesting momentum has built quickly as data center and electric utility...

Inter & Co, Inc. recently reported first-quarter 2026 results showing higher net interest income of R$1.88 billion and net income of R$394.79 million year on year, and in mid-May also presented at the 19th Annual LatAm CEO Conference in New York and an NDR event in Rio de Janeiro. This combination of stronger quarterly earnings and elevated implied volatility in October 2026 call options has drawn fresh attention to investor expectations around Inter & Co’s next phase. We’ll now examine how...

ICL Group (NYSE:ICL) is expanding in China with a new food specialty plant, targeting higher value ingredients for the local market. The company has also entered a major distribution agreement in China to widen access to its specialty products. At the same time, ICL is growing its specialty fertilizers business in North America, adding another leg to its international buildout. ICL Group operates across specialty minerals, advanced fertilizers and food ingredients, so these moves align...

In the last week, the United States market has stayed flat, yet it is up 27% over the past year with earnings expected to grow by 17% per annum in the coming years. In this context, identifying stocks that may be undervalued by the market involves looking for companies whose intrinsic value might not be fully reflected in their current share prices despite these positive growth trends.

The market remained flat over the last week but has shown a robust 27% increase over the past year, with earnings projected to grow by 17% annually. In this context, identifying growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the business and have shown impressive revenue growth.